• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Report: 7,800 Florida clinical trials conducted since 1999

Report: 7,800 Florida clinical trials conducted since 1999

September 16, 2013
CenterWatch Staff

Working in collaboration with Florida clinicians and research institutions, America’s biopharmaceutical research companies have conducted more than 7,800 clinical trials of new medicines in Florida over the last 14 years, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA).

The new report, Research in Your Backyard:  Pharmaceutical Clinical Trials in Florida, said these trials have benefited thousands of Floridian patients, the state’s economy and the advancement of science and patient care. 

“Today’s findings in the report underscore the importance of our efforts to ensure that the state has a strong research infrastructure,” said Nancy Bryan, president and chief executive officer of BioFlorida. “Policymakers and legislators in the state understand the necessity of a strong biopharmaceutical presence to patients and the economy.”

Nearly half of the clinical trials of new medicines have been aimed at chronic diseases, including cancer, diabetes, heart disease, stroke, asthma and mental illnesses. Nearly 700 of those trials are still active and recruiting patients.

The report also details how the biopharmaceutical sector is boosting Florida employment and the state’s economy. Nearly 84,000 jobs were sector-supported in the state in 2011, including 22,438 workers employed directly by biopharmaceutical companies. Direct biopharmaceutical wages and benefits resulted in about $1.6 billion in 2011 compensation, generating more than $276 million in tax money for the state and federal governments. 

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing